阿斯利康加大在中国筹码,收购合作伙伴子公司

财经大健康
22 Feb

AI课题、减肥药、入职、收购,为关键词图/视觉中国No.1看涨减肥药,礼来近40亿元押库存跨国药企礼来大举押注还在试验中的减肥药。据媒体报道,2月20日,礼来在报告后期试验数据之前,就对其实验性口服减肥药Orforglipron加大押注,在财务报表中记录了近5.5亿美元(约合人民币39.77亿)的“上市前库存”。这一举动很不寻常,因为此时距离该药物的预计上市时间还有一年多的时间。通常,大多数制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10